Details for New Drug Application (NDA): 207577
✉ Email this page to a colleague
The generic ingredient in VERARING is ethinyl estradiol; etonogestrel. There are twenty-six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; etonogestrel profile page.
Summary for 207577
Tradename: | VERARING |
Applicant: | Dr Reddys Labs Sa |
Ingredient: | ethinyl estradiol; etonogestrel |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | RING;VAGINAL | Strength | 0.015MG/24HR;0.12MG/24HR | ||||
Approval Date: | Dec 9, 2021 | TE: | RLD: | No |
Complete Access Available with Subscription